About this trial
Pre-eclampsia (PE) is a pregnancy-associated syndrome of variable severity, classically defined by the combination of hypertension and proteinuria in a previously non-hypertensive or proteinuric patient. These symptoms normally resolve within 2-3 months after delivery regardless of the severity of the pre-eclampsia.
Regardless of its definition, preeclampsia is associated with an increased risk of obstetric events and, for the mother, an increased risk of developing chronic kidney disease (CKD), hypertension, diabetes and cardiovascular disease in the broad sense.
The relationship between preeclampsia and Chronic Kidney Disease is, however, complex and not fully understood.
Investigator proposes an interventional study to identify the diagnosis of Chronic Kidney Disease in patients who have developed an episode of Preeclampsia.
Eligibility criteria
Qualifiers
Meeting the preeclampsia criteria or one of its complications (eclampsia, HELLP syndrome) according to the ISSHP 2018 definitions within the last 5 years
Having signed the informed consent
Person affiliated to social security
Disqualifiers
Patient with mental disability or language barrier preventing understanding of the study or consent
Person deprived of liberty by judicial or administrative decision
Person under forced psychiatric care
Person subject to a legal protection measure
Trial design
Treatments tested in this trial
- annual follow-up during 10 years